Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of Talkspace (NasdaqCM:TALK) with a Buy recommendation. Analyst Price Forecast Suggests 82.80% Upside As of April 2, 2025, ...

Deal with Cantor Fitzgerald comes almost two years after Canaccord warned of a potentially ‘significant penalty’ related to ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...

Canaccord Genuity analyst Katie Lachapelle maintained a Buy rating on Sigma Lithium (SGML – Research Report) today and set a price target of ...

Sale of U.S. market making business reinforces alignment of Canaccord Genuity's U.S. business with its global capital markets platform TORONTO, April 1, 2025 /CNW/ - Canaccord Genuity Group Inc ...

MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a price target of ...

Canaccord Genuity Group restated their speculative buy rating on shares of Spirent Communications (LON:SPT – Free Report) in ...